Molecular Confirmation of t(6;11)(p21;q12) Renal Cell Carcinoma in Archival Paraffin-embedded Material Using a Break-apart TFEB FISH Assay Expands its Clinicopathologic Spectrum

被引：111

作者：

Argani, Pedram ^{[1
,2
]}

Yonescu, Raluca ^{[1
]}

Morsberger, Laura ^{[1
]}

Morris, Kerry ^{[1
]}

Netto, George J. ^{[1
,2
]}

Smith, Nathan ^{[1
]}

Gonzalez, Nilda ^{[1
]}

Illei, Peter B. ^{[1
]}

Ladanyi, Marc ^{[3
]}

Griffin, Constance A. ^{[1
,2
]}

机构：

[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA

[2] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA

来源：

AMERICAN JOURNAL OF SURGICAL PATHOLOGY | 2012年 / 36卷 / 10期

关键词：

TFEB; TFE3; FISH; translocation; renal cell carcinoma; GENE FUSION; TRANSLOCATION CARCINOMAS; CHROMOSOME-TRANSLOCATION; CATHEPSIN-K; TUMOR; IMMUNOREACTIVITY; EXPRESSION; NEOPLASMS; FEATURES; T(6/11);

D O I：

10.1097/PAS.0b013e3182613d8f

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

A subset of renal cell carcinomas (RCCs) is characterized by t(6;11)(p21;q12), which results in fusion of the untranslated Alpha (MALAT1) gene to the TFEB gene. Only 21 genetically confirmed cases of t(6; 11) RCCs have been reported. This neoplasm typically demonstrates a distinctive biphasic morphology, comprising larger epithelioid cells and smaller cells clustered around basement membrane material; however, the full spectrum of its morphologic appearances is not known. The t(6; 11) RCCs differ from most conventional RCCs in that they consistently express melanocytic immunohistochemical (IHC) markers such as HMB45 and Melan A and the cysteine protease cathepsin K but are often negative for epithelial markers such as cytokeratins. TFEB IHC has been proven to be useful to confirm the diagnosis of t(6; 11) RCCs in archival material, because native TFEB is upregulated through promoter substitution by the gene fusion. However, IHC is highly fixation dependent and has been proven to be particularly difficult for TFEB. A validated fluorescence in situ hybridization (FISH) assay for molecular confirmation of the t(6; 11) RCC in archival formalin-fixed, paraffin-embedded material has not been previously reported. We report herein the development of a break-apart TFEB FISH assay for the diagnosis of t(6; 11)(p21; q12) RCCs. We validated the assay on 4 genetically confirmed cases and 76 relevant expected negative control cases and used the assay to report 8 new cases that expand the clinicopathologic spectrum of t(6; 11) RCCs. An additional previously reported TFEB IHC-positive case was confirmed by TFEB FISH in 46-year-old archival material. In conclusion, TFEB FISH is a robust, clinically validated assay that can confirm the diagnosis of t(6; 11) RCC in archival material and should allow a more comprehensive clinicopathologic delineation of this recently recognized neoplastic entity.

引用

页码：1516 / 1526

页数：11

共 33 条

[1]

[Anonymous], 2004, TUMORS URINARY SYSTE

[2]

Antic T, 2007, MODERN PATHOL, V20, p135A

[3] Renal carcinomas with the t(6;11)(p21;q12) -: Clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR [J].

Argani, P ;

Laé, M ;

Hutchinson, B ;

Reuter, VE ;

Collins, MH ;

Perentesis, J ;

Tomaszewski, JE ;

Brooks, JSJ ;

Acs, G ;

Bridge, JA ;

Vargas, SO ;

Davis, IJ ;

Fisher, DE ;

Ladanyi, M .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (02) :230-240

[4] Translocation carcinomas of the kidney after chemotherapy in childhood [J].

Argani, P ;

Laé, M ;

Ballard, ET ;

Amin, M ;

Manivel, C ;

Hutchinson, B ;

Reuter, VE ;

Ladanyi, M .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (10) :1529-1534

[5] PRCC-TFE3 renal carcinomas -: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21) [J].

Argani, P ;

Antonescu, CR ;

Couturier, J ;

Fournet, JC ;

Sciot, R ;

Debiec-Rychter, M ;

Hutchinson, B ;

Reuter, VE ;

Boccon-Gibod, L ;

Timmons, C ;

Hafez, N ;

Ladanyi, M .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (12) :1553-1566

[6] A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23) [J].

Argani, P ;

Lui, MY ;

Couturier, J ;

Bouvier, R ;

Fournet, JC ;

Ladanyi, M .

ONCOGENE, 2003, 22 (34) :5374-5378

[7] Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions -: A sensitive and specific immunohistochemical assay [J].

Argani, P ;

Lal, P ;

Hutchinson, B ;

Lui, MY ;

Reuter, VE ;

Ladanyi, M .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) :750-761

[8] Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma -: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents [J].

Argani, P ;

Antonescu, CR ;

Illei, PB ;

Lui, MY ;

Timmons, CF ;

Newbury, R ;

Reuter, VE ;

Garvin, AJ ;

Perez-Atayde, AR ;

Fletcher, JA ;

Beckwith, JB ;

Bridge, JA ;

Ladanyi, M .

AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :179-192

[9] A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation [J].

Argani, P ;

Hawkins, A ;

Griffin, CA ;

Goldstein, JD ;

Haas, M ;

Beckwith, JB ;

Mankinen, CB ;

Perlman, EJ .

AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) :2089-2096

[10] Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum [J].

Argani, Pedram ;

Olgac, Semra ;

Tickoo, Satish K. ;

Goldfischer, Michael ;

Moch, Holger ;

Chan, David Y. ;

Eble, John N. ;

Bonsib, Stephen M. ;

Jimeno, Mireya ;

Lloreta, Josep ;

Billis, Athanase ;

Hicks, Jessica ;

De Marzo, Angelo M. ;

Reuter, Victor E. ;

Ladanyi, Marc .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (08) :1149-1160

← 1 2 3 4 →